IL-33 drives polyfunctionality and antitumor activity of a unique ST2+ NK cell population
biorxiv(2023)
摘要
Natural Killer (NK) cell subsets differ to ensure complementary and crucial roles in tumor immunosurveillance. Their biology is critically regulated by cytokines. Here, we show that IL-33 synergizes with IL-12 to strongly activate a subset of CD56dim NK cells acquiring ST2 expression. Transcriptomic and biological analysis of human ST2+ CD56dim NK cells revealed a distinct intermediate differentiation state between canonical CD56bright and CD56dim NK cells, combining high proliferative properties, cytokines/chemokines production, and cytotoxicity. NK cells expressing ST2 protein or exhibiting a ST2-linked transcriptional signature were identified in human and mouse tumors. Accordingly, IL-12 unleashes human breast tumor ST2+ NK cell potential to produce IFN-γ in response to IL-33 and IL-33/IL-12 co-injection resulted in a NK-dependent IFN-γ secretion and anti-tumor effects in murine mammary tumors. An IL33hi-NKhi score in solid tumors correlated with increased progression-free patient survival. Our findings thus identify polyfunctional ST2+ NK cells which effector functions can be harnessed by IL-33 to boost anti-tumor immunity.
### Competing Interest Statement
The authors have declared no competing interest.
更多查看译文
关键词
antitumor activity,unique st2+,cell
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要